<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Bhuvan Srinivasan on Medium]]></title>
        <description><![CDATA[Stories by Bhuvan Srinivasan on Medium]]></description>
        <link>https://medium.com/@viggen?source=rss-1a08d32ead9d------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*dmbNkD5D-u45r44go_cf0g.png</url>
            <title>Stories by Bhuvan Srinivasan on Medium</title>
            <link>https://medium.com/@viggen?source=rss-1a08d32ead9d------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Mon, 16 Nov 2026 01:00:52 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@viggen/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Plant — based meat: What’s a startup to do?]]></title>
            <link>https://viggen.medium.com/plant-based-meat-whats-a-startup-to-do-6b537f4467e0?source=rss-1a08d32ead9d------2</link>
            <guid isPermaLink="false">https://medium.com/p/6b537f4467e0</guid>
            <category><![CDATA[food]]></category>
            <category><![CDATA[beyond-meat]]></category>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[plant-based-diets]]></category>
            <category><![CDATA[sustainability]]></category>
            <dc:creator><![CDATA[Bhuvan Srinivasan]]></dc:creator>
            <pubDate>Sun, 18 Apr 2021 14:14:40 GMT</pubDate>
            <atom:updated>2021-04-18T14:14:40.646Z</atom:updated>
            <content:encoded><![CDATA[<h3>Plant — based meat: What’s a startup to do?</h3><p>“<em>You can always count on Americans to do the right thing — after they’ve tried everything else” — Winston Churchill</em></p><p><em>“You can always count on Americans to eat plant-based meat— after it tastes like meat” — someone famous (soon)</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*5ZdCFKHwlq1OirDq" /><figcaption><em>Source: plantbasednews.org</em></figcaption></figure><p><strong>Summary</strong></p><ul><li>While Covid-19 captured the headlines in 2020 and 2021 a plant food revolution has been brewing — consumers are curious about plant-based meat and intend to increase their consumption of plant-based food</li><li>By giving consumers the meaty flavors they expect, rather than expecting them to sacrifice on taste, plant-based meat companies have succeeded where lentil burgers and vegan burgers have failed</li><li>Beyond Meat and Impossible Foods dominate the headlines and the market; but high growth and low loyalty provide a window for startups with the right playbook</li></ul><p><strong>Step 1: Decide to accept your mission</strong></p><p>While the 20th Century was full of strange advertising that told you what to think or do (remember “The Best A Man Can Get”¹ or “Once you pop, you can’t stop”² or “Put a tiger in your tank”³), most businesses in the last two decades have been mission focused. E.g. Google talks about “organizing the world’s information”⁴ not about being “the OG of monetizing intent”.</p><p>This is because social responsibility has become important to the young consumer. <strong>When it comes to food, more than 70% of consumers under 34 believe that social responsibility is Extremely/Very Important.</strong></p><p>Everyone knows that the mission is forward looking and you won’t be able to live up to it for a long time. But they also have to know that you’ll die trying to make it happen — <strong>authenticity is more important than accuracy</strong>.</p><p><strong>Pick a mission, articulate it well, stay true to it.</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/786/1*dF0NsAgW2MDLwau4eq48bg.png" /><figcaption>Source: Jefferies Research⁵</figcaption></figure><p><strong>Step 2: Set up for rapid innovation</strong></p><p>If you are a chicken farmer you grow every chicken the same, whether it’s for Kentucky Fried Chicken (KFC) or for a McDonald’s Chicken McNuggets or for a chicken parmesan (yes there are different varieties of chickens but that’s not the point). The same applies for cow and hog farmers.</p><p>Plant-based meat is not the same. The requirements for each customer and each dish are different, especially as you go from ground meat to solid pieces. This is why Impossible Foods and Beyond Meat started with ground beef and sausages because it was easier than recreating the tissue of a steak. This is also why plant-based chicken did not take off earlier even though Beyond Meat sold a frozen chicken product — they had not perfected the texture.</p><p>So when Beyond tied up with KFC they had to spend 6 months coming up with chicken that worked for KFC⁶. Or when Beyond launched ground pork in China, it was designed specifically to replicate the flavor profile of pork in China⁷.</p><p><strong>Each meat, each geography, each dish will require R&amp;D and innovation — be ready for it.</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/596/1*A-RnsEcTIc249FmOsMb78w.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/596/1*Sr5iFoK5jho_3svnBpGBzQ.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*VMnbrJsEfQZQTpXt0B8leQ.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/780/1*RWb_YeD98P277h2gyRE3Yw.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/596/1*WMM4C8Ty8noJIOa4RIWGKw.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*VMnbrJsEfQZQTpXt0B8leQ.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/780/1*RWb_YeD98P277h2gyRE3Yw.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*DlSOmBMnNOG7SPJdgrDDMw.jpeg" /><figcaption>Sources: cnn.com, koko.news, fastcompany.com³</figcaption></figure><p><strong>Step 3: Focus first on taste above everything</strong></p><p>What about health? What about price? What about saving the planet?</p><p>No — focus on taste. For years people have been trying to convince Americans to eat more plants with little success (it’s a different story for Europeans⁸).</p><p><em>“America would appear to be losing its appetite for British celebrity chef Jamie Oliver …Food Revolution has hit the skids in Los Angeles after 75 school districts rebuffed his pleas to give their canteens a healthy makeover.”</em>⁹</p><p><em>“Eat food. Not too much. Mostly plants.” </em>— Michael Pollan¹⁰</p><p><em>“Mark Bittman has a golden rule for eating well: Eat more plants, less junk and fewer animal products”¹¹</em></p><p>Many people turned vegan over the years for various reasons but the majority of folks remain stubbornly carnivorous. <strong>They do not want to be told what they can and cannot eat. They liked what they eat, and health, animal cruelty, global warming are trumped by taste</strong>. This is where the real revolution has been. A Kroger study found, 93% of people who bought Beyond Burger had other animal proteins in their cart⁶.</p><p><em>“Beyond Fried Chicken certainly is as guilty, salty, chewy, herbaceous, and umami-loaded of an experience as the KFC you know.” ⁶</em></p><p><em>“Without taste, there’s no repeat purchase.”¹²</em> — Dasha Shor (food analyst)</p><p><strong>Taste is the only thing that changes buying behavior — get it right.</strong></p><p><strong>Step 4: Help people lose weight</strong></p><p>Losing weight could be the killer app of plant-based meat</p><p><em>“specifically in China, one of the reasons for people to buy plant-based meat, actually the biggest reason, is the wish to lose weight.” — Mirte Gosker, acting MD at the Good Food Institute Asia Pacific¹³</em></p><p>Today plant-based beef does not deliver on this. While it can claim a big reduction in trans fat and cholesterol, saturated fats, sodium and calories are not significantly different. Bottomline — it’s significantly better for the planet (see Step 6) but not significantly better for you. If there’s a great way for a startup to differentiate itself from the pack, it’s to help people lose weight.</p><p><strong>People will pay anything to lose weight — help them.</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/563/1*gZXjFlD1eMSVPswq57UYfg.png" /><figcaption>Source: Stephens⁸</figcaption></figure><p><strong>Step 5: Bring pricing down below regular meat</strong></p><p>If you have completed Steps 1–4, chances are you are starting to see traction and volumes are going up. What was initially a small bespoke production process can then be scaled up.</p><p>While industrialized meat production has become very efficient over time, there’s no way for it to match the cost of production of plant based meat. Roughly twenty-five times more energy is required to produce one calorie of beef than to produce one calorie of corn for human consumption¹⁴ and that will eventually be reflected in the cost of production of plant-based meat.</p><p>Given that taste (tackled in Step 3) and cost are the two most important factors in the adoption of plant-based meat⁵, solving them will ensure greater volume, starting a virtuous cycle of lower cost and more adoption.</p><p><strong>Step 6: Get specific on how you are saving the planet</strong></p><p>There are many studies laying out how much better plant-based meat is for the environment, from water consumption to greenhouse gas emission. This is a well accepted fact by consumers and at least in the beginning you should not spend time and effort on a well-accepted theme.</p><p>However, once you do scale up, it’s critical to be rigorous and accurate in quantifying all the good that the consumer is doing by supporting you. Like a luxury good, it’s not just about the attributes of the product, it’s how it makes you feel.</p><p><strong>Collect and share the numbers to make people feel good about saving the planet.</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/803/1*PHnWDkuexAUmsjWEMGfW3Q.png" /><figcaption>Source: Stephens⁸</figcaption></figure><p><strong>Conclusion</strong></p><p>Those who felt strongly about saving the planet, animal cruelty or health have already moved to a plant-based diet and remain the minority.</p><p>The rest don’t want to be guilt-tripped or shamed into getting healthier or saving the planet by eating plant-based meat. <strong>They want food that they are used to, at a reasonable price — make them happy. In the process you’ll save lives and save the planet in six easy steps.</strong></p><p><strong>References</strong></p><ol><li><a href="https://gillette.com/en-us/about/the-best-men-can-be">https://gillette.com/en-us/about/the-best-men-can-be</a></li><li><a href="https://youtu.be/77rKo-WdULY">1996 — “Once You Pop, You Can’t Stop”</a></li><li><a href="https://www.exxon.com/en/history">Exxon Mobil: Our History</a></li><li><a href="https://blog.google/products/search/information-sources-google-search">Google Blog: Organizing the world’s information, where does it all come from?</a></li><li>Jefferies — Lower Pricing the Adoption Accelerator: A Dive into Plant-Based Food — April 9th, 2021</li><li><a href="https://www.fastcompany.com/90455889/kfcs-beyond-meat-chicken-is-a-damn-miracle">KFC’s Beyond Meat chicken is a miracle</a> — January 29th, 2020</li><li>Stephens — Beyond Meat’s China facility to speed up growth — April 7th, 2021</li><li>Stephens — Initiating Coverage Beyond Meat — March 18th, 2021</li><li><a href="https://www.dailymail.co.uk/news/article-1348158/U-S-loses-appetite-Jamie-Oliver-75-LA-school-districts-turn-away-Food-Revolution-show.html">U.S. loses appetite for Jamie Oliver as 75 LA school districts turn away his Food Revolution show</a></li><li><a href="https://michaelpollan.com/reviews/how-to-eat/">How to Eat: Diet secrets from Michael Pollan (and your great-grandma)</a></li><li><a href="https://www.nbcnews.com/better/health/why-mark-bittman-wants-you-be-part-time-vegan-ncna889916">Why Mark Bittman wants you to be a part-time vegan</a></li><li><a href="https://www.bostonglobe.com/2021/04/13/lifestyle/nothing-squawk-plant-based-chicken-is-pretty-delicious-verge-major-breakthrough/">Nothing to squawk at: Plant-based ‘chicken’ is pretty delicious — and on the verge of a major breakthrough — The Boston Globe</a> — April 13th, 2021</li><li><a href="https://www.cnbc.com/2021/04/07/karana-creating-asias-first-whole-plant-based-alternative-meat-brand.html">Creating pork from jackfruit: How this whole-plant start-up is taking on Asia’s multibillion-dollar meat industry</a> — April 7th, 2021</li><li><a href="http://List of Foods by Environmental Impact and Energy Efficiency">The Oil: List of Foods by Environmental Impact and Energy Efficiency</a></li></ol><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6b537f4467e0" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Electronic Health Records: The dark side of platform durability]]></title>
            <link>https://viggen.medium.com/electronic-health-records-the-dark-side-of-platform-durability-94a9e23b1fbd?source=rss-1a08d32ead9d------2</link>
            <guid isPermaLink="false">https://medium.com/p/94a9e23b1fbd</guid>
            <category><![CDATA[electronic-health-record]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[physician-burnout]]></category>
            <category><![CDATA[platform-economy]]></category>
            <category><![CDATA[regulation]]></category>
            <dc:creator><![CDATA[Bhuvan Srinivasan]]></dc:creator>
            <pubDate>Sun, 11 Apr 2021 18:39:32 GMT</pubDate>
            <atom:updated>2021-04-11T18:39:32.211Z</atom:updated>
            <content:encoded><![CDATA[<h3>Electronic Health Records: The Dark Side of Platform Durability</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*z8eGFdF0wQUHrcCOGBezGQ.jpeg" /><figcaption><a href="http://hcrnetwork.com/"><em>Source</em></a></figcaption></figure><h3>Summary</h3><ul><li>Electronic Health Records (EHRs) were meant to facilitate an exchange of information across different doctors to improve patient health outcomes. However EHR companies have catered to the money side (hospital administrators) and by being driven by regulation rather than by end-users (i.e. patients), they have become a tool hated by doctors and irrelevant for patients.</li><li>The durability of EHR companies is remarkable (same vintage as Microsoft and Apple) — they have weathered the protection and expansion phase successfully while competing with giant companies like Google, Microsoft and Amazon; their strategies are worth studying.</li><li>Regulation, which enabled their growth, has also recently taken away a key advantage by forcing inter-operability. If patients are lucky it might force a rethink and make EHR companies focus on improving health outcomes as well.</li></ul><h3>Introduction: What are EHRs?</h3><p>Initially the healthcare system was simple, patients went to doctors. Doctors gave advice and patients gave money (Figure 1). Doctors tended to have simple handwritten notes which described diagnosis and treatment.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/523/1*e7oPt8R70MXwbqt9zRO-yQ.png" /><figcaption>Figure 1</figcaption></figure><p>As health insurance and government coverage (e.g. Medicare) became more prevalent, the system evolved. Doctors gave advice, patients paid payors (premiums in the case of private health insurance companies or taxes for Medicare) and payors paid the doctor (Figure 2). It became important for the doctor to communicate the diagnosis and the treatment to the payor in order to get paid.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/523/1*fHQ0KpRoSpGcOH-U-Qqudg.png" /><figcaption>Figure 2</figcaption></figure><p>Over time healthcare became further regulated. In addition, as the population aged and specialization increased, care was provided across multiple settings including hospitals (with multiple doctors), primary care clinics and other doctor practices. <strong>The humble handwritten note then evolved into an electronic document containing the notes of the doctor including exams conducted, clinical observations, and information of the severity of the case.</strong></p><p>Hospital administration also became specialized in response to increasing complexity and administrators, not doctors, made key decisions including what to spend capital on. Hence their concerns were reflected in how EHRs were built and implemented (Figure 3).</p><ol><li>The key concern of hospital administrators was to get paid by payors and to remain compliant with regulations and this received the majority of attention.</li><li>The exchange of information between a hospital and other doctors was severely hampered if the other doctor did not use the same system.</li><li>Patients rarely had access to their own data.</li><li>Doctors using the EHRs experienced burnout because of the disproportionate amount of time spent on updating the EHR vs. actually listening to and treating the patient.</li></ol><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*mH6UoezNbBNhhECwuBUvvA.png" /><figcaption>Figure 3</figcaption></figure><h3>Why are EHRs a platform?</h3><p>EHRs have key platform characteristics including:</p><ol><li>Create value outside — EHRs are meant to facilitate hospital/doctor payments and improve patient health outcomes.</li><li>Multiple participants — EHRs are the key enablers of information exchange across various participants — doctors, payors and patients.</li><li>Network effects — EHRs are critical for patient assessment and treatment. Hence as more hospitals implement a particular EHR (e.g. Epic), others are likely to also opt for the same one.</li></ol><h3>Who are the key players?</h3><p>Cerner and Epic are the leading players in the EHR market and are the focus of this article.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*EljTj9HJ_hlaorL2e_iPFg.png" /><figcaption>Source: Cerner 2020 Annual Report (Page 5)</figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/474/0*f0JYC76yWVFutK6i" /></figure><p>Epic was founded in 1979 by Judith R. Faulkner and is headquartered in Verona, Wisconsin¹. Epic has a large share of private sector hospitals and is often chosen for its usability and departmental functionality. Furthermore, a recent study showed Epic is associated with significantly higher performance in key regulation (e.g. Stage 2 Meaningful Use requirements) over competitors Cerner, Allscripts, and MEDITECH².</p><p>Many marquee institutions such as the Cleveland Clinic, Johns Hopkins and Boston Children’s Hospital have chosen Epic. The company’s 564 customers represent nearly 2,400 hospitals worldwide and 225 million patients in the U.S., or about two thirds of the country’s population³.</p><p>Revenue — 2007: $500mm, 2010: $1bn, 2020: $3.3bn</p><p>EBITDA margin: &gt;30%</p><p>Debt: none</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/474/0*jJRAIDfPw8zAMeem" /></figure><p>Cerner was founded in 1979 by Neal Patterson, Paul Gorup, and Cliff Illig, who were colleagues at Arthur Andersen. Today it is one of the largest health IT companies in the world.</p><p>Key stats:</p><ol><li>Revenue — 2010: $1.9bn, 2020: $5.6bn</li><li>Operating earnings — 2010: $359mm (19.4%), 2020: $915mm (16.6%)</li><li>Market cap — 2010: $7.9bn, 2020: $24bn</li><li>&gt;650k physician users, &gt;2.2mm non-physician users</li></ol><h3>Why do EHRs suck?</h3><ol><li>Focus on billing not patient outcomes</li></ol><p>EHRs have evolved to almost exclusively serve the needs of the money side i.e. hospital administrators. Administrators are focused on revenue (billing to payors) and regulatory compliance. Where the focus on billing is reduced (e.g. the Veterans Affairs medical system), the EHRs are more focused on doctor convenience and readability⁴.</p><p>2. Increased load on physicians</p><p>Physicians in the United States may spend half their day filling out patient histories. A 2018 study in Family Medicine found that of 982 patient visits that each lasted on average for 35.8 min, 19.3 min were spent on the EHR⁵.</p><p>Or more evocatively, as Dr. Abraham Verghese writes:</p><p><em>“The despair I hear (from a doctor) comes from being the highest-paid clerical worker in the hospital: For every one hour we spend cumulatively with patients … we spend nearly two hours on our primitive Electronic Health Records, or “E.H.R.s,” and another hour or two during sacred personal time. But we are to blame. We let this happen to our trainees, to ourselves.” ⁶</em></p><p>3. No improvement in patient outcomes</p><p>It is estimated that the impact of EHR implementation has been a miniscule 0.09% lower mortality; in fact mortality was 11% higher mortality in the early days of implementation (2008) due to confusion and bad data entry⁷.</p><p>Dr. Abraham Verghese again:</p><p><em>“Our $3.4 trillion health care system is responsible for more than a </em><strong><em>quarter of a million deaths per year because of medical error</em></strong><em>, the rough equivalent of, say, a jumbo jet’s crashing every day… a result of poorly coordinated care, poor communication, patients falling through the cracks, </em><strong><em>knowledge not being transferred</em></strong><em> and so on, but some part of it is surely from </em><strong><em>failing to listen to the story</em></strong><em> and diminishing skill in reading the body as a text.” ⁶</em></p><h3>What strategies have players adopted for platform protection?</h3><p>Despite not serving two of the main constituents (patients and doctors), EHR companies have been extremely durable and grown well. Epic’s average customer has been using its software for ten years, and Epic’s founder claims the company has never lost an in-patient hospital client, except in the case of an acquisition³. In fact Epic and Cerner are examples of rare tech companies which have been around since the 1970s (and earlier) and are still market leaders today. Their esteemed peers include IBM, Intel, Microsoft and Apple, showing their durability. In fact Google, Microsoft and Amazon have tried to make inroads into various healthcare platforms but failed. Hence their strategies are worth understanding.</p><ol><li>Focus on the money side</li></ol><p>EHRs are extremely expensive. Epic commands a 10x price differential with potentially lower cost, more agile solutions⁵. E.g. Florida based Advent Health plans to deploy Epic’s EHR system across 37 hospitals at a cost of $650mm and ongoing annual maintenance cost in millions³. Boston based Partners Healthcare spent $1.2bn in 2015 implementing Epic. Given the high cost, EHR companies have focused on the money side i.e. the hospital administrators at the cost of the doctors and patients. This is the key reason why EHRs are focused on billing and regulation rather than doctor ease-of-use and patient transparency.</p><p><em>“</em><strong><em>The decision to implement Epic comes from administrators and non-clinicians who are most invested in revenue </em></strong><em>…major driver for the creation of EHRs was because billing is so complex due to the shitshow that is the U.S. healthcare insurance industry... </em><strong><em>Related to this, hospital administrators want different tools than doctors do.</em></strong><em> Admins are very interested in detailed documentation for reporting, quality improvement, etc. Unfortunately, </em><strong><em>this is often a pain in the ass for clinicians</em></strong><em>.” — Medicine Subreddit¹⁶</em></p><p>2. New tech is not the only thing that matters — focus on the human element</p><p>The adoption of new technology in healthcare is slower because the “moving fast and breaking things” approach doesn’t mean an app freezes, it means someone might die.</p><p>“It’s not okay to fail. That’s death.” — John Glaser, Harvard Medical School³</p><p>As a result EHR companies have focused on incremental innovation rather than breakthrough innovation. They also focus on the people aspect by deploying their own staff (sometimes hundreds or thousands) on site to get the platform deployed — this is a high touch platform more than a high tech platform.</p><p>3. Walled garden and lack of interoperability</p><p>Before 2020, EHRs were not interoperable i.e. one company’s EHR could be opened easily by another company’s software (e.g. Epic’s EHR could not be opened on Cerner’s software).</p><p><em>“I can’t reliably get a patient record from across town, let alone from a hospital in the same state, even if both places use the same brand of E.H.R. … too often the record comes by fax” — Dr. Abraham Verghese⁶</em></p><p>This was a key strategy to prevent easy migration from one system to another. It also meant that once the larger players in the healthcare system (i.e. hospitals) adopted a certain brand, other players (e.g. standalone doctors outside of the hospital) would need to invest in the same system in order to serve the same patients.</p><p>The lack of interoperability also means that new players cannot disintermediate the EHR incumbent because of the data stored in a proprietary format.</p><p>4. Lobbying</p><p>When regulation promoting interoperability was likely to be pushed through, Epic’s founder wrote a letter a letter urging executives of major hospitals to take a stand with the Epic and advocate against parts of the proposed rule. In response, roughly 60 hospitals pledged their loyalty to Epic⁸.</p><p>5. Legal pressure</p><p>In 2014 Epic sued Tata Consultancy Services which had been hired by Kaiser Foundation Hospitals to implement hospital software. Epic alleged that Tata had built another software which as a rip-off of Epic’s software. A Wisconsin jury awarded Epic $240 million in compensatory damages and $700 million in punitive damages⁹. While this amount was later revised downwards¹⁰, it was a warning shot fired at anyone who competed with Epic.</p><p>6. High switching costs and multihoming costs</p><p>Given the financial cost and deployment complexity of implementing an EHR system, hospitals are unlikely to switch EHR systems once implemented.</p><p>7. Being responsive to regulation</p><p>EHR companies continue to remain flexible. In March 2020 the Office of the National Coordinator (ONC) and the Centers for Medicare and Medicaid Services (CMS) published rules for the interoperability of EHRs. While Epic had initially lobbied against the rules, it later changed its stance and started supporting them.</p><p>In December 2020, Epic reported that its interoperability software, Care Everywhere, shared more than 221 million patient records in a month, an increase of 40 percent year over year¹². In fact Epic installations accelerated during the pandemic with more than 190 health systems going live¹².</p><h3>What strategies have players adopted for platform expansion?</h3><ol><li>Strong emphasis on share of wallet</li></ol><p>EHR companies have evolved to address many parts of the hospital workflow (continuing to focus on hospital administrators) including revenue cycle management, customer retention tools and data analytics³. This further increases switching cost and reduces multi-homing.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*qimdQkYS89KP8ZKU_TJ-Qw.jpeg" /><figcaption>Source: Authenticmedicine.com</figcaption></figure><p>2. Capability expansion — using big data and AI for therapeutics development</p><p>Real-world data (RWD) are the data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources including EHRs¹³. Real-world evidence (RWE) is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of RWD. After the 21st Century Cures Act was passed in 2016, pharmaceutical and medical device companies could use RWE to supplement or substitute (in rare cases) traditional clinical trials for drug and device approval.</p><p>Given their access to hospital data EHR companies could be at the forefront of the RWE revolution. E.g. Cerner has declared a goal of building a $1bn+ data business¹⁴. In December 2020 Cerner acquired Kantar Health for $375mm. Kantar Health is a leading data, analytics and real-world evidence and commercial research consultancy serving the life science industry¹⁴. Cerner has also tied up with Amazon to bring new technologies to healthcare (e.g. cloud delivery, Artificial Intelligence and Machine Learning)¹⁷.</p><p>Its important to note that the success of EHR companies in this space will be dependent on:</p><ul><li><strong>Ability to sell to a new set of clients</strong> — EHR companies are used to selling to hospitals, and specifically hospital administrators. It will be important for them to gain the skills and relationships to sell into pharmaceutical and medical device companies, likely through M&amp;A.</li><li><strong>Ability to work with other EHR companies’ data </strong>— the ability to access as much RWD as possible is critical to building a strong RWE business.</li><li><strong>Ability to marry EHR data with other data sources</strong> — many startup companies are marrying non-EHR data (e.g. genomic data) with EHR data to provide a complete picture of the patient population. E.g. The Clinico-Genomic Database, codeveloped by Flatiron Health and Foundation Medicine, links the genomic data of 120,000 cancer patients to their longitudinal EMR data. That is creating an unprecedented opportunity to integrate data sources and generate deeper insights through advanced analytics¹⁵. It’s unclear if EHR companies will be able to do this.</li><li>Ability to compete on innovation — Covid-19 and the new interoperability rules have resulted in a huge investment by venture capital firms behind healthtech, health apps and digital health. This will certainly increase the competition and Epic’s and Cerner’s large scale expensive installations will look outdated unless they change quickly³. Even if they are able to pivot their software, their business model pivot (away from multi-billion dollar deployments) will be more difficult.</li></ul><p><em>“We are right in the middle of this phenomenal transformational swirl…just as the Web and smartphones crushed Microsoft’s seemingly unassailable 1990s-era desktop monopoly, this new era may pose the same challenges for Faulkner (Epic’s founder)” — John Glaser, Harvard Medical School³</em></p><h3>Conclusion</h3><p>EHR companies represent extremely durable platforms (similar vintage as Microsoft and Apple) which have stayed relevant through relentless focus on the money side (i.e. hospital administrators) and a variety of other strategies.</p><p>Regulation, which enabled their growth, has also recently taken away a key advantage by forcing inter-operability. If patients are lucky it might force a rethink and make EHR companies focus on improving health outcomes as well.</p><h3>References</h3><ol><li><a href="https://en.wikipedia.org/wiki/Epic_Systems">https://en.wikipedia.org/wiki/Epic_Systems</a></li><li><a href="https://ehrintelligence.com/news/amp/top-50-most-popular-hospital-inpatient-ehr-systems-in-us">Top 50 Most Popular Hospital Inpatient EHR Systems in US</a></li><li><a href="https://www.forbes.com/sites/katiejennings/2021/04/08/billionaire-judy-faulkner-epic-systems/?sh=3cf3d56c575a">The Billionaire who controls your medical records</a></li><li><a href="https://www.youtube.com/watch?v=QPm98D8APF0&amp;t=4s">What The VA Got Right | When Charting Doesn’t Suck</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913749/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913749/</a></li><li><a href="https://nyti.ms/2vZhl60">HOW TECH CAN TURN DOCTORS INTO CLERICAL WORKERS</a></li><li><a href="https://youtu.be/gYNE0tBJopI">Electronic Medical Record (EMR) Overview</a></li><li><a href="https://ehrintelligence.com/news/epic-leads-almost-60-health-systems-against-interoperability-rule">Epic Leads Almost 60 Health Systems Against Interoperability Rule</a></li><li><a href="https://www.reuters.com/article/us-tata-epic-verdict-idUSKCN0XD135">Epic Systems wins $940 mln U.S. jury verdict in Tata trade secret case</a></li><li><a href="https://indianexpress.com/article/explained/tata-consultancy-services-us-court-140-million-us-dollars-damages-epic-system-6565782/">Explained: Why does TCS need to pay $140 million in damages to Epic Systems?</a></li><li><a href="https://www.fiercehealthcare.com/tech/after-fierce-opposition-ehr-giant-epic-now-supports-onc-cms-interoperability-rules">After fierce opposition, EHR giant Epic now supports ONC, CMS interoperability rules</a></li><li><a href="https://www.beckershospitalreview.com/ehrs/5-updates-on-epic-and-interoperability.html">5 updates on Epic and interoperability</a></li><li><a href="https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence">Real-World Evidence</a></li><li><a href="https://ehrintelligence.com/news/ehr-vendor-cerner-eyes-developing-a-1-billion-data-business">EHR Vendor Cerner Eyes Developing a $1 Billion Data Business</a></li><li><a href="https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/genetic-testing-opportunities-to-unlock-value-in-precision-medicine">Genetic testing: Opportunities to unlock value in precision medicine</a></li><li><a href="https://www.reddit.com/r/medicine/comments/9znmjq/why_is_ehr_software_so_bad/">Why is EHR software so bad?</a></li><li><a href="https://www.cerner.com/aws">What’s next changes everything — Cerner and AWS</a></li></ol><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=94a9e23b1fbd" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Neuralink Brand Strategy]]></title>
            <link>https://viggen.medium.com/neuralink-brand-strategy-ad35551ceb90?source=rss-1a08d32ead9d------2</link>
            <guid isPermaLink="false">https://medium.com/p/ad35551ceb90</guid>
            <category><![CDATA[elon-musk-neuralink]]></category>
            <category><![CDATA[biomedical-engineering]]></category>
            <category><![CDATA[neuroscience]]></category>
            <category><![CDATA[brain-computer-interface]]></category>
            <category><![CDATA[artificial-intelligence]]></category>
            <dc:creator><![CDATA[Bhuvan Srinivasan]]></dc:creator>
            <pubDate>Fri, 19 Feb 2021 19:58:24 GMT</pubDate>
            <atom:updated>2021-02-19T19:58:24.232Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*B6D0h-X3EPBC9UEY" /><figcaption><em>Source: https://neuralink.com/</em></figcaption></figure><p><strong>Key disruptive themes</strong>: 1. Direct-to-consumer marketing (pre-purchase) via Elon Musk’s star power and on social media (not common for medical devices) 2. Bypassing doctors via robotics (during purchase phase) 3. Seeding confusion via cyborg talk.</p><p><strong>Recommendations</strong>: 1. Earn the respect of researchers and doctors, don’t piss them off — you can’t do this alone. Don’t pander to Elon fan boys. 2. Stick with communication around improving health (cyborgs can come later) 3. Don’t overpromise; do overdeliver — this is someone’s life not their sexy car.</p><h3><strong>Introduction</strong></h3><h4>What is Neuralink and why is it important</h4><ul><li>Medical science has made tremendous strides in understanding various parts of the body and curing their respective afflictions. However, it has largely focused on the simpler systems, namely the circulatory system including the heart (i.e the pump and the plumbing), the skeleton (i.e. the chassis) and the muscles (i.e. the horsepower). We have developed many therapies (e.g. cholesterol medication, blood pressure medication) and interventions (e.g. hip implants, stents) in order to treat issues in these systems.</li><li>The brain remains the most important but least understood organ in the body. When it comes to dealing with neurological injury (e.g. paralysis) or mental health issues (e.g. schizophrenia) we remain in the dark ages with crude devices and medications to address critical issues.</li><li>Neuralink is a company that is attempting to create a system that can be implanted in the brain to treat some of these conditions. Unfortunately it is today known more for being an Elon Musk company than an innovative flagbearer for patients.</li><li>The mission of the company is to create a high bandwidth brain machine interface (BMI). This system consists of a device that is implanted in the brain, as well as a robot that implants this device. In the first phase the company hopes to treat neurological issues. In the second phase the company hopes that the interface helps direct human-to-human “telepathic” communication without the need to speak or exchange written text. In the third phase the company hopes to enable humans to have a symbiotic relationship with artificial intelligence (yes you read that right).</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/474/0*2ym1VwqWRr8_2Zzc" /><figcaption><a href="https://www.futuristgerd.com/wp-content/uploads/2020/09/neuralink-installation.jpg">Neuralink implant</a></figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1003/0*MRCR3VT3axa5708t.png" /><figcaption><a href="https://d1lss44hh2trtw.cloudfront.net/assets/editorial/2020/08/neuralink-progress-update-summer-2020-robot-surgery.png">Elon Musk with the Neuralink Robot</a></figcaption></figure><h4>Why is this difficult</h4><ul><li>The brain is extremely complicated. The <a href="https://en.wikipedia.org/wiki/Human_brain">1.2–1.4 kg organ</a> is only 2% of the body’s weight but controls our bodily functions, our emotions, our thoughts as well as enables us to experience consciousness.</li><li>It does this by using a large number of cells (<a href="https://www.brainfacts.org/core-concepts/your-complex-brain">86–100 billion neurons</a>) but more importantly structuring them as a network. <a href="https://aiimpacts.org/scale-of-the-human-brain/">Each neuron is estimated to have up to 1,000 connections to other neurons</a>.</li><li>The computing power of the brain comes from the number of connections as well as the strength of the individual connections. The structure and connections evolve differently for each human as they experience the world, learn skills and create memories (known as neuroplasticity) — the implication is that each person’s brain is different anatomically and functionally — what works for one person will not work for another.</li><li>As we look to address issues in the brain we have to account for this complexity and variance.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*d77SHFuVq3mWqKuv.jpg" /><figcaption><a href="https://media.buzzle.com/media/images-en/gallery/human-biology/brain/1200-492386370-neurons-cell-brain.jpg">Depiction of a neuron network</a></figcaption></figure><h4>Where are we today — various methods</h4><p><em>(an illustrative list to provide an overview)</em></p><ul><li>There are multiple methods of “reading” (measuring brain activity) or “writing” (stimulating neurons) but they have severe limitations.</li><li>fMRI — (+) non-invasive (-) low temporal resolution (-) cannot “write” (-) low bandwidth</li><li>EEG — (+) non-invasive (-) low spatial resolution (-) cannot “write” (-) low bandwidth</li><li>DBS — (-) invasive (-) low area of coverage (+) can “write” (-) low bandwidth</li><li>Neuralink (proposed) — (-) invasive (+) high area of coverage (+) can “write” (+) high bandwidth</li></ul><h3><strong>Clock model</strong></h3><ul><li>A medical device is different from a normal consumer product in that there are many stakeholders involved. Stakeholders for a consumer product — producer, regulator, distributor, customer. Stakeholders for a medical device — producer, regulator, distributor, <strong>insurer</strong>, <strong>doctor</strong>, patient. The decision makers are typically the doctor and the insurer rather than the patient. Neuralink so far has flipped this, speaking directly to potential patients and users.</li></ul><h4>Pre-purchase</h4><ul><li><strong>Elon Musk presentations </strong>— despite his stuttering and filler words Elon Musk is the heir of Steve Jobs’ — he has the ability to create a reality distortion field. His presentations and interviews generate much interest in his companies including Neuralink. His Neuralink presentations are typically for a layperson rather than a doctor which is how most medical marketing works. E.g. he plays up the fact that Neuralink received a breakthrough device classification as if it’s unique while in reality the <a href="https://www.medtechdive.com/news/neuromodulation-fda-breakthrough-devices/587617/">FDA has approved multiple devices in this category in a hurry</a>.</li><li><strong>YouTube videos published by the company</strong> — to <a href="https://youtu.be/-gQn-evdsAo">https://youtu.be/-gQn-evdsAo</a></li><li><strong>YouTube videos published by fans</strong> (example below) which go into depth and synthesize various sources in Elon Musk’s presentations, various tweets and rumors (free publicity!)</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*mv4dOMihC4gJmf_i" /></figure><ul><li><strong>Twitter </strong>— both Elon Musk (<a href="https://twitter.com/elonmusk">47.3M followers</a>) and the Neuralink management are active on Twitter to keep up the excitement around the company. Medical devices take a long time to go from the lab to a widely available product so manufacturers tend to stay away from early marketing because it’s difficult to capture the audience’s attention over a multi-year period. Elon’s star power however makes this possible for Neuralink.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/743/0*fet4hNLlQf_68wuk" /></figure><h4>Purchase</h4><ul><li>While Neuralink is currently not available for purchase, it is expected to be available via the usual channels but with key differences.</li><li><strong>Doctors and Insurers — Typical </strong>— The typical purchase decision in the case of medical devices is made in the following fashion: a patient visits a doctor with a symptom, the doctor analyses the symptom to understand the core problem and recommends solutions, the solution that is covered by the patient’s health insurance program is then chosen. In this workflow the doctor and insurer act as gatekeepers who determine what the patient receives and are thus the targets for marketing investment by medical device companies i.e. “push” marketing.</li><li><strong>Doctors and Insurers — Neuralink</strong>— In the case of Neuralink the tremendous pre-purchase publicity will likely result in patients going to their doctors and insurers and asking for the device — a rare example of “pull” marketing in medical devices. This is <a href="https://medicalmarcom.com/medical-device-marketing/direct-to-consumer/">typically not done in medical devices</a>: 1. If you advertise to the patient, the doctor easily can talk him/her out of the superiority claim saying, “I’ve done many surgeries the old way successfully” and “you have nothing to worry about.” 2. If you succeed in generating patient pull, it will likely come at a much greater patient acquisition cost than alternate ways to convince your points of distribution to use your product. In the case of Neuralink there’s a push to replace the doctor (see the following bullet) which might make the doctor less relevant (making “pull” marketing more effective) and the pre-purchase publicity via Elon Musk makes patient acquisition free in the “pull” model vs. trying to “push” via doctors.</li><li><strong>Surgery at the hospital — </strong>the Neuralink device has extremely precise and delicate electrodes (many times smaller than a strand of hair). While this makes the device more effective, it also makes it more fragile and also requires extremely accurate placement. Thus Neuralink also created a robot to ensure successful implantation. While the robot greatly enhances the effectiveness of the device, it is also the company’s trojan horse so that in the future specialist doctors (e.g. neurosurgeons) might not be required for implantation.</li></ul><h4>Post-purchase</h4><ul><li><strong>Tuning</strong>: Like other devices (e.g. pacemakers, deep brain stimulation) the Neuralink device is likely to require to be tuned/customized after implantation to be effective. The neuroplasticity of each brain requires a large degree of personalization and hence there will be multiple visits to the hospital and doctor post implant.</li><li><strong>Software upgrades</strong>: Tesla is famous for upgrading its cars “over-the-air” and Neuralink will likely be no different. This will be a huge advantage over other companies which are typically stuck with legacy software and hardware (<a href="https://www.wsj.com/articles/how-volkswagens-50-billion-plan-to-beat-tesla-short-circuited-11611073974">like the car companies that Tesla competes against</a>).</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*LLy0kiH-qECAXFpc0zXp_A.png" /><figcaption><a href="https://www.wsj.com/articles/how-volkswagens-50-billion-plan-to-beat-tesla-short-circuited-11611073974">Software is a key differentiator for Tesla</a></figcaption></figure><ul><li><strong>Replacement</strong>: implants eventually fail or need to be upgraded and this will required a skilled surgeon to remove the device from a patient’s skull.</li></ul><h3><strong>Brand audit</strong></h3><h4>Positives</h4><ul><li><strong>Elon Musk</strong> — wunderkind, genius, world’s richest man, 47.3mm followers</li><li><strong>Founding team</strong> — includes multi-disciplinary experts from semiconductors, biomaterials, cloud computing, brain-machine interfaces</li><li><strong>Potential for incredible impact </strong>— the team is focused on launching a product that can help with severe brain injuries (stroke, cancer lesion, congenital problems)</li><li><strong>Innovation (for the layperson)</strong>— the precision of the electrodes, the robot, the association with Elon Musk hint at tremendous innovation whereas the traditional companies in the space (e.g. Medtronic, Boston Scientific) are viewed as dinosaurs</li></ul><h4>Negatives</h4><ul><li><strong>Overhyped</strong> <strong>(according to the experts)</strong>— many BMI researchers are annoyed with the claims that Elon Musk has made. Their view is that what Neuralink has achieved so far is the same as other companies or research labs. This is a not a good image for the company since it will need to collaborate with researchers over time to make the device better.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Yzc2G7R_Dxr0NQgRrdY09Q.png" /><figcaption><a href="https://www.wired.com/story/neuralink-is-impressive-tech-wrapped-in-musk-hype/">https://www.wired.com/story/neuralink-is-impressive-tech-wrapped-in-musk-hype/</a></figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/953/1*D-OANOzmkZuivqSPhPZBpg.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/949/1*XtM2Hz-VjEV3TEvjNc5stQ.png" /><figcaption><a href="https://www.inverse.com/innovation/neuralink-neuroscientists">https://www.inverse.com/innovation/neuralink-neuroscientists</a></figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/751/0*mOtYT6cXg-zXPNTC" /></figure><ul><li><strong>Invasive</strong>: Neuralink’s device needs to be implanted and is invasive which means that regardless of how badly healthy early adopters want it, it will face hurdles transitioning beyond severe brain conditions. If the company wants a more mass market device it will need to transition to a non-invasive device but might struggle if it has already pissed off researchers with hype (see previous point).</li><li><strong>Concerns about BMI</strong>: Surveys suggest that the public is not comfortable with the idea of having an implant in their brain even if it improves cognitive abilities (see below).</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/415/0*qnsOeDQGNApkFtdp.png" /></figure><ul><li><strong>Cyborg confusion</strong>: Elon’s and Neuralink’s public goals of melding humans and computers, and later human intelligence and artificial intelligence, certainly don’t help the concerns the public has about BMI. This detracts significantly from the more immediate mission of the company to help people with severe brain conditions.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/761/1*3Q5IAUd7qXnh1KFyKoiPkA.png" /><figcaption><a href="https://www.psychologytoday.com/us/blog/the-future-brain/201907/how-elon-musks-neuralink-plans-unify-the-brain-ai">Psychology Today</a></figcaption></figure><h3><strong>Brand identity model</strong></h3><h4>What it is</h4><ul><li><strong>Brand essence</strong> — become a cyborg and one with AI (see above)</li><li><strong>Core identity </strong>— high bandwidth telepathic communication with other humans</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/729/1*n4h6pjgnKrVSSxl7LHBfzw.png" /></figure><ul><li><strong>Extended identity </strong>— help with severe brain conditions. Brand as a person: the Borg. Brand as a symbol: Neuralink robot.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*BRwkMRtdaue1i6xt.jpg" /><figcaption>Brand as a person: You will be assimilated</figcaption></figure><h4>What it should be</h4><ul><li><strong>Brand essence </strong>— should focus on health and regaining capabilities — “feel whole again”, “feel human again”, get back your ability to move</li><li><strong>Core identity </strong>— breakthrough innovation and cutting edge technology, democratizing health through low cost and high availability (miniaturization and automation is expected to reduce cost dramatically)</li><li><strong>Extended identity </strong>— Brand as a person: paralyzed person who can walk again. Brand as a symbol: Neuralink robot. Brand as an organization: diverse (company video potentially shows transgender engineer — see below), multi-disciplinary.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/819/0*DaPnhH0FQUaaRhIe" /><figcaption>Brand as an organization: expressive, diverse, multi-disciplinary</figcaption></figure><h3>Recommendations</h3><h4>Earn the respect of researchers and doctors, don’t piss them off — you can’t do this alone. Don’t pander to Elon fan boys.</h4><ul><li>Healthcare has a lot of stakeholders and decision makers, unlike a consumer product</li><li><strong>Researchers </strong>— unfortunately they think that Elon Musk talking about “reading” and “writing” to the brain makes their research look less like science and more like science fiction. While Neuralink and Elon Musk might be fine with this (there’s a lot of good science fiction on this topic) serious researchers would have an issue with this and would not want to collaborate with Neuralink — this will slow the company down. E.g. they will need to collaborate when they want to make the move from invasive to non-invasive technology.</li><li><strong>Doctors</strong> — like it or not Neuralink will have to depend on doctors for implanting, tuning and replacing the devices (at least initially). Neuralink needs to recognize the tremendous influence doctors hold and not talk about replacing them with robots.</li><li><strong>Consumers </strong>— unfortunately the communication seems to focused on the public and these are the folks who are most excited about Neuralink — in the initial phase of the company they don’t matter! Neuralink doesn’t need fan boys. We are at least 10 years away from this being a product for the public (according to Elon Musk). According to science fiction writer Ramez Naam it could be another 50 years.</li></ul><h4>Stick with communication around improving health (cyborgs can come later)</h4><ul><li>Talking about telepathic communication, AI symbiosis is a complete distraction from serious science and delivering care to disabled patients. It reduces the credibility of the company in front of scientists and doctors.</li><li>Neuralink does NOT have to give up its long term goals, it just needs to focus on communicating the shorter term benefits. Paul Graham of YCombinator (world’s pre-eminent startup incubator) says: <a href="http://paulgraham.com/ambitious.html">“You’d expect big startup ideas to be attractive, but actually they tend to repel you…Even the most ambitious people are probably best off approaching them obliquely.”</a></li><li>Once the initial phase (delivering results to patients with brain conditions) is successful Neuralink can embark on the next phase. If indeed this is the cure against AI taking over the world everyone will be a lot more receptive once Neuralink proves itself by tackling relatively simpler challenges, and when/if the threat of AI becomes more real.</li><li><strong>Potential issues with recommendation</strong>: Elon Musk is as concerned about AI as he is about climate change, and he’s using Neuralink as one of the means to deliver the message (he also support OpenAI which is trying to Open Source AI). Reducing communication about the future phases of Neuralink could be viewed as defeating the whole point of funding Neuralink. My view is that communicating a vision that sounds like science fiction reduces the credibility of Neuralink, ultimately preventing it from reaching its goal.</li></ul><h4>Don’t overpromise; do overdeliver — this is someone’s life not their sexy car</h4><ul><li>It’s good to create excitement about how you are trying to help people but it would also be viewed as misleading severely disabled people into thinking their issues can be solved without having much evidence. Telling someone they might have an electric car in 5 years and disappointing them is NOT the same as promising to cure paralysis and not delivering.</li><li><strong>Potential issues with recommendation</strong>: One of Elon Musk’s strategies is to keep broadcasting a vision that feels 20–30 years in the future and then to deliver it in 10–20 years, accelerating the future (as he calls it). This requires putting a vision out there as a call to action (and even a threat) to everyone in the ecosystem to mobilize their resources to reach the future faster. Toning down expectations could potentially reduce the speed of innovation. The difference in the case of BMI is that it’s not as established industry like the car industry with multiple large companies who can be pushed to pivot. It’s a small niche industry so there are no incumbents to threaten/push.</li></ul><p><em>Note: recommendations are largely in the pre-purchase and purchase category because the company has not yet launched a commercial version of the device. Post-purchase investment will be extremely important post launch— investing in doctor relationships and managing patient expectations (as recommended) will result in greater likelihood of success post-purchase.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ad35551ceb90" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>